Expand ABOS Menu
ABOS MENU

ABOS Latest Press Releases

-- June 17, 2026 --

JCR Pharmaceuticals Announces That Acumen Pharmaceuticals Has Exercised its Exclusive Option to Develop Therapeutic Candidates for Alzheimer's Disease, Enabled by J-Brain Cargo Technology Platform Business Wire 12:30 PM

-- June 16, 2026 --

Acumen Pharmaceuticals Announces Nomination of Two Enhanced Brain Delivery (EBD ) Development Candidates for the Treatment of Alzheimer's Disease Globe Newswire 7:30 AM

-- May 12, 2026 --

Acumen Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Highlights Globe Newswire 7:00 AM

-- May 7, 2026 --

Acumen Pharmaceuticals to Participate in the Bank of America Securities 2026 Health Care Conference Globe Newswire 4:00 PM

-- May 5, 2026 --

Acumen Pharmaceuticals to Report First Quarter Financial Results on May 12, 2026 Globe Newswire 4:00 PM

-- March 26, 2026 --

Acumen Pharmaceuticals Reports Financial Results for the Year Ended December 31, 2025 and Business Highlights Globe Newswire 7:00 AM

-- March 19, 2026 --

Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2025 Financial Results on March 26, 2026 Globe Newswire 4:00 PM

-- March 17, 2026 --

Acumen Pharmaceuticals Presents Studies on Enhanced Brain Delivery , Biomarker Research, and Novel Antibodies at Advances in Alzheimer's Treatment at International Conference on Alzheimer's and Parkinson's Diseases 2026 Globe Newswire 8:00 AM

-- March 16, 2026 --

Acumen Pharmaceuticals Announces $35.75 Million Private Placement to Advance Potential Best-in-Class Molecules from Amyloid Beta Oligomer-Selective Enhanced Brain Delivery Portfolio Globe Newswire 6:30 AM

-- March 10, 2026 --

Acumen Pharmaceuticals to Participate in the Stifel 2026 Virtual CNS Forum Globe Newswire 4:00 PM

-- March 3, 2026 --

Acumen Pharmaceuticals to Showcase Advances in Alzheimer's Treatment at International Conference on Alzheimer's and Parkinson's Diseases 2026 Globe Newswire 8:00 AM
Market Data Delayed 15 Minutes